Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.950
+0.110 (3.87%)
Jul 18, 2025, 4:00 PM - Market closed
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.53 million as of July 18, 2025. Its market cap has increased by 48.26% in one year.
Market Cap
4.53M
Enterprise Value
822.46K
1-Year Change
48.26%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.53M, a decrease of -95.00%. That is a compound annual growth rate of -47.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 4.36M | 13.13% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.63B |
| Johnson & Johnson | 392.14B |
| AbbVie | 338.09B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 261.32B |
| Novartis AG | 227.25B |
| AstraZeneca | 214.46B |
| Abbott Laboratories | 209.67B |